Viewing Study NCT00077259


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-01-02 @ 4:32 AM
Study NCT ID: NCT00077259
Status: COMPLETED
Last Update Posted: 2013-01-16
First Post: 2004-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module